ArticleJournal of inflammation research2025
A Retrospective Observational Analysis of Factors Determining the Formation of Pressure Ulcers in ICU Patients Treated for COVID-19.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictors of Pressure Injury Development and Clinical Course in ICU Patients: A Retrospective Cohort Study.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Critically ill COVID-19 patients are at heightened risk for pressure ulcers (PUs), with the pandemic altering both the frequency and location of PU development and challenging hospital preparedness. The study aimed to investigate clinical and demographic factors associated with PUs in critically ill COVID-19 patients, compared outcomes between those who did and did not develop PUs, and assessed the impact of septic shock, prone positioning, and other interventions on PU formation, prolonged hospitalization, and mortality. Materials and Methods: A retrospective analysis was conducted on 160 adults with lab-confirmed COVID-19 treated in the intensive care unit (ICU) of the 4 Results: PUs occurred in 48.12% (n=77) of patients. Septic shock was more prevalent among those with PUs (30.12% vs 16.88%, p=0.049). PUs group had higher mean SAPS II scores (56.40) and greater argipressin use (0.50 units, p=0.015). Length of stay was significantly longer for patients with PUs (mean=14.08 days, p<0.001). Multivariate analysis showed that higher SAPS II scores, argipressin use, and extended hospitalization were independent risk factors, while 28-day survival was protective against PUs formation. Conclusion: PUs development in critically ill COVID-19 patients is strongly linked to disease severity, vasopressor requirements, and prolonged hospitalization. Targeted preventive measures focusing on these risk factors could help mitigate PUs incidence and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.